Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
cefuroximnatrium 750 mg/15 ml injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 1,5 mg/25 ml injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 7,5 g/100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 7,5 g/pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
Cefuroxime sodium 750mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 1,5 g pulver til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 15 mg/ml injektionsvæske, opløsning, pose a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroximnatrium 30 mg/ml injektionsvæske, opløsning, pose a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
cefuroxim 750 mg pulver til injektionsvæske, rekonstitution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
|
Product containing precisely cefuroxime (as cefuroxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 50 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/50 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 1.5 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefuroxime (as cefuroxime sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 1.5 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |
Cefuroxime (as cefuroxime sodium) 750 mg powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefuroxime sodium |
Inferred relationship |
Some |
1 |